ROTONDI, MARIO
 Distribuzione geografica
Continente #
NA - Nord America 10.411
AS - Asia 6.567
EU - Europa 4.737
SA - Sud America 1.013
Continente sconosciuto - Info sul continente non disponibili 418
AF - Africa 221
OC - Oceania 6
Totale 23.373
Nazione #
US - Stati Uniti d'America 9.982
CN - Cina 2.762
SG - Singapore 1.525
IE - Irlanda 1.015
IT - Italia 866
HK - Hong Kong 809
BR - Brasile 762
VN - Vietnam 652
RU - Federazione Russa 547
UA - Ucraina 456
DE - Germania 428
FI - Finlandia 380
FR - Francia 346
GB - Regno Unito 272
BD - Bangladesh 181
SE - Svezia 171
CA - Canada 154
IN - India 122
JP - Giappone 108
AR - Argentina 89
ZA - Sudafrica 88
MX - Messico 80
IQ - Iraq 63
NL - Olanda 58
PK - Pakistan 46
TR - Turchia 44
EC - Ecuador 43
PL - Polonia 41
ID - Indonesia 40
CR - Costa Rica 34
MA - Marocco 32
VE - Venezuela 32
ES - Italia 28
CO - Colombia 24
PH - Filippine 24
CL - Cile 23
BE - Belgio 22
GT - Guatemala 22
JM - Giamaica 22
SA - Arabia Saudita 22
UZ - Uzbekistan 22
AT - Austria 21
IL - Israele 20
HN - Honduras 19
NI - Nicaragua 18
MY - Malesia 17
TT - Trinidad e Tobago 16
KE - Kenya 15
PY - Paraguay 15
TN - Tunisia 15
JO - Giordania 14
CW - ???statistics.table.value.countryCode.CW??? 13
SV - El Salvador 12
DZ - Algeria 11
PR - Porto Rico 11
AE - Emirati Arabi Uniti 10
AL - Albania 10
ET - Etiopia 10
KR - Corea 10
NP - Nepal 10
UY - Uruguay 10
BB - Barbados 9
CH - Svizzera 9
GP - Guadalupe 9
SC - Seychelles 9
LT - Lituania 8
PA - Panama 8
AZ - Azerbaigian 7
BO - Bolivia 7
EE - Estonia 7
EG - Egitto 7
DO - Repubblica Dominicana 6
AO - Angola 5
EU - Europa 5
HR - Croazia 5
KZ - Kazakistan 5
MC - Monaco 5
OM - Oman 5
PS - Palestinian Territory 5
RO - Romania 5
RS - Serbia 5
TH - Thailandia 5
CI - Costa d'Avorio 4
CZ - Repubblica Ceca 4
GA - Gabon 4
IR - Iran 4
KG - Kirghizistan 4
LB - Libano 4
LV - Lettonia 4
MM - Myanmar 4
PE - Perù 4
AU - Australia 3
BH - Bahrain 3
BY - Bielorussia 3
GE - Georgia 3
GR - Grecia 3
KH - Cambogia 3
MU - Mauritius 3
NG - Nigeria 3
QA - Qatar 3
Totale 22.913
Città #
San Jose 1.116
Dublin 1.015
Chandler 963
Dallas 803
Hong Kong 783
Ashburn 740
Singapore 685
Council Bluffs 627
Jacksonville 585
Nanjing 528
Beijing 428
Boardman 320
Lauterbourg 234
Ho Chi Minh City 225
Los Angeles 219
Princeton 213
Nanchang 204
Lawrence 198
Wilmington 174
Hebei 166
Hanoi 151
Shenyang 149
Changsha 147
Santa Clara 143
Medford 139
New York 135
Milan 126
Jiaxing 116
Buffalo 115
Moscow 105
Tokyo 104
Helsinki 99
Rome 89
Shanghai 85
Tianjin 79
Redondo Beach 77
Hangzhou 76
Ann Arbor 73
São Paulo 72
Munich 71
Johannesburg 67
Orem 54
Columbus 52
The Dalles 47
Naples 46
Woodbridge 46
San Francisco 45
Chicago 41
Piscataway 40
Mexico City 39
Verona 38
Warsaw 37
Brooklyn 36
North Bergen 36
Da Nang 34
Falls Church 33
Atlanta 32
Haiphong 32
Toronto 32
Montreal 31
Falkenstein 30
Phoenix 30
Seattle 29
Houston 28
San José 28
Dhaka 27
Frankfurt am Main 27
Stockholm 27
San Genesio Ed Uniti 26
Norwalk 25
Guangzhou 24
Pavia 24
Chennai 23
Florence 23
London 23
Baghdad 21
Belo Horizonte 21
Boston 21
Brussels 21
Nuremberg 21
Rio de Janeiro 21
Amsterdam 18
Curitiba 18
Denver 18
Turku 18
Ankara 17
Managua 17
Manchester 17
Philadelphia 17
Turin 17
Washington 17
Bari 16
Fairfield 16
Tashkent 16
Zhengzhou 16
Brasília 15
Guatemala City 15
Kunming 15
Amman 14
Auburn Hills 14
Totale 14.026
Nome #
The in vitro effects of Voghera sweet pepper on thyroid cancer cells: modulation of oxidative stress and pro-tumorigenic genes 380
Painful Hashimoto's thyroiditis: myth or reality? 336
Anti-Mullerian hormone as a predictor of ovarian reserve in ART protocols: The hidden role of thyroid autoimmunity 162
Age-dependent changes in CXC chemokine ligand 10 serum levels in euthyroid subjects. 158
Effect of Interferon-γ on the Basal and the TNF α-Stimulated Secretion of CXCL8 in Thyroid Cancer Cell Lines Bearing Either the RET/PTC Rearrangement or the BRAF V600e Mutation 156
Advancing age and insulin resistance: role of plasma tumor necrosis factor-alpha. 153
A male patient with acromegaly and breast cancer: Treating acromegaly to control tumor progression 151
A unique presentation of Graves' disease in a pregnant woman with severe hypothyroidism 146
A Unique Patient Presenting with Concomitant Klinefelter Syndrome, Alport Syndrome and Craniopharyngioma. 145
An improved polymerase chain reaction (PCR) protocol for unambigous detection of growth hormone gene deletions. 144
Performance of the ACR TI-RADS and EU TI-RADS scoring systems in the diagnostic work-up of thyroid nodules in a real-life series using histology as reference standard 144
A hypoechoic pattern of the thyroid at ultrasound does not indicate autoimmune thyroid diseases in patients with morbid obesity. 143
Disabling portosystemic encephalopathy in a non-cirrhotic patient: Successful endovascular treatment of a giant inferior mesenteric-caval shunt via the left internal iliac vein 141
Management of subclinical hypothyroidism in pregnancy: a comment from the Italian Society of Endocrinology and the Italian Thyroid Association to the 2017 American Thyroid Association Guidelines: "The Italian Way" 136
TNF-α increases the membrane expression of the chemokine receptor CCR6 in thyroid tumor cells, but not in normal thyrocytes: potential role in the metastatic spread of thyroid cancer 135
Etiopathogenesis of Basedow's disease. Trends and current aspects 134
An unusual therapeutic approach to a large thyroid nodule 130
CB1 receptor antagonism/inverse agonism increases motor system excitability in humans. 128
Compared with classic Hashimoto’s thyroiditis, chronic autoimmune serum-negative thyroiditis requires a lower substitution dose of l-thyroxine to correct hypothyroidism 127
Adverse effects of in vitro GenX exposure on rat thyroid cell viability, DNA integrity and thyroid-related genes expression 126
In vitro study of the UV-filter homosalate effects on rat and human thyroid cells 125
Prevalence of Double Pituitary Adenomas in a Surgical Series: Clinical, Histological and Genetic Features. 124
Disease modifying therapies in multiple sclerosis: Could a baseline thyroid check-up drive the therapeutic choice between interferon-β and glatiramer acetate? 124
Autoimmune thyroid disorders and rheumatoid arthritis: A bidirectional interplay 124
Acute kidney injury promotes development of papillary renal cell adenoma and carcinoma from renal progenitor cells 123
THYREOTROPIN LEVELS IN DIABETIC PATIENTS ON METFORMIN TREATMENT. 122
Body weight changes in a large cohort of patients subjected to thyroidectomy for a wide spectrum of thyroid diseases 120
Autoimmune thyroid diseases in patients treated with alemtuzumab for multiple sclerosis: An example of selective anti-TSH-receptor immune response 120
DIAGNOSIS OF ENDOCRINE DISEASE: IgG4-related thyroid autoimmune disease 120
A first-trimester serum TSH in the 4-10 mIU/L range is associated with obstetric complications in thyroid peroxidase antibody-negative women 119
Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections. 119
Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy. 118
Basal and longitudinal changes in serum levels of TSH in morbid obese patients experiencing failure or success of dietary treatment 118
Seronegative autoimmune diseases: A challenging diagnosis 117
Expanding the therapeutic spectrum of metformin: From diabetes to cancer 116
Occurrence of thyroid autoimmunity and dysfunction throughout a nine-month follow-up in patients undergoing interferon-beta therapy for multiple sclerosis. 115
Post partum and non-post partum relapsing Graves' hyperthyroidism display different response to anti-thyroid drugs 115
Extraocular muscle antibodies positivity as the only serum marker of euthyroid Graves' ophthalmopathy following subacute thyroiditis: case report. 114
Vitamin D and interferon-γ co-operate to increase the ACE-2 receptor expression in primary cultures of human thyroid cells 112
Risk of coronary heart disease and mortality for adults with subclinical hypothyroidism. 112
Shear wave elastography in the diagnosis of thyroid nodules: feasibility in the case of coexistent chronic autoimmune Hashimoto's thyroiditis 112
Laser photocoagulation therapy for thyroid nodules: long-term outcome and predictors of efficacy 112
Development of chronic pain in males with traumatic spinal cord injury: role of circulating levels of the chemokines CCL2 and CXCL10 in subacute stage 111
Type I and type II interferons inhibit both basal and tumor necrosis factor-α-induced CXCL8 secretion in primary cultures of human thyrocytes. 110
Reverse phenotyping after whole-Exome sequencing in steroid-resistant nephrotic syndrome 109
Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis 109
Early spermatogenesis changes in traumatic complete spinal cord-injured adult patients 108
2017 ATA guidelines on the management of thyroid dysfunctions in pregnancy: what do OB/GYNs need to know? 108
Inflamm-ageing: How cytokines and nutrition shape the trajectory of ageing 107
Changing the structure of PFOA and PFOS: a chemical industry strategy or a solution to avoid thyroid-disrupting effects? 106
Longitudinal study of antibodies against thyroid in patients undergoing interferon-alpha therapy for HCV chronic hepatitis. 106
Low insulin resistance and preserved beta-cell function contribute to human longevity but are not associated with TH-INS genes. 106
Graves' disease. 106
A new mechanism involving ERK contributes to rosiglitazone inhibition of tumor necrosis factor-alpha and interferon-gamma inflammatory effects in human endothelial cells. 106
Balancing the need for rapid and rigorous scientific data during early phase of the COVID-19 pandemic: A further role for the scientific community 106
Maternal hypothyroidism and subsequent neuropsychological outcome of the progeny: a family portrait 105
Thyroid Disrupting Effects of Old and New Generation PFAS 105
Parity as a thyroid size-determining factor in areas with moderate iodine deficiency. 104
Diabetes insipidus and increased serum levels of leptin and lactate-dehydrogenase (LDH) in an adolescent boy with a primary intracranial germinoma. Case report and an endocrinological revaluation of literature. 104
Interferon-related thyroid autoimmunity and long-term clinical outcome of chronic hepatitis C. 104
Nivolumab induced thyroid dysfunction: Unusual clinical presentation and challenging diagnosis 104
Impaired outcome of controlled ovarian hyperstimulation in women with thyroid autoimmune disease. 103
Multicenter study on TGPO autoantibody prevalence in various thyroid and non-thyroid diseases; relationships with thyroglobulin and thyroperoxidase autoantibody parameters. 103
Elevated serum interferon-gamma-inducible chemokine-10/CXC chemokine ligand-10 in autoimmune primary adrenal insufficiency and in vitro expression in human adrenal cells primary cultures after stimulation with proinflammatory cytokines. 102
Intraepidermal nerve fiber density reduction as a marker of preclinical asymptomatic small-fiber sensory neuropathy in hypothyroid patients. 102
Increased serum reverse triiodothyronine levels at diagnosis of hepatocellular carcinoma in patients with compensated HCV-related liver cirrhosis. 101
The AMPK-activator AICAR in thyroid cancer: effects on CXCL8 secretion and on CXCL8-induced neoplastic cell migration 101
Vitamin D Reduces Thyroid Cancer Cells Migration Independently From the Modulation of CCL2 and CXCL8 Chemokines Secretion 100
High CXCL10 expression in rejected kidneys and predictive role of pretransplant serum CXCL10 for acute rejection and chronic allograft nephropathy. 99
Toxic Diffuse Goiter (Basedow-Graves' Disease) 99
Pretransplant Positivity for Circulating Thyroid Antibodies and Graft Survival in Patients Undergoing Kidney Transplant. 99
COVID-19 Pulmonary and Olfactory Dysfunctions: Is the Chemokine CXCL10 the Common Denominator? 99
Ultrasound of benign thyroid nodules: a 120 months follow-up study 99
Selenium supplementation in patients with subclinical hypothyroidism affected by autoimmune thyroiditis: Results of the SETI study 99
Effect of long- and short-chain perfluorinated compounds on cultured thyroid cells viability and response to TSH 99
Effects of increased thyroxine dosage pre-conception on thyroid function during early pregnancy. 98
Serum CXCL10 levels and occurrence of thyroid dysfunction in patients treated with interferon-alpha therapy for hepatitis C virus-related hepatitis. 98
Expression of estrogen and androgen receptors in differentiated thyroid cancer: an additional criterion to assess the patient's risk. 98
The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system 98
Patients with chronic autoimmune thyroiditis are not at higher risk for developing clinically overt thyroid cancer: A 10-year follow-up study 98
Lack of association between changes in plasma leptin concentration and in food intake during the menstrual cycle. 97
Metodo diagnostico per la previsione di rigetto di organo trapiantato 97
Proficiency in performing radiofrequency ablation procedure for non-functioning benign thyroid nodules: a qualitative rather than quantitative matter 95
The addition of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism. 95
CXCL8 in thyroid disease: From basic notions to potential applications in clinical practice. 95
The Amh as a predictor of ovarian reserve and the role of thyroid autoimmunity in the protocols of assisted reproduction techniques 95
-to: Nicoletti F, Conget L, Di Mauro M et al. (2002) Serum concentrations of the interferon-alpha-inducible chemokine IP-10/CXCL10 are augmented in both newly-diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease. Diabetologia 45:1107-1110. 94
Normal human thyroid cells, BCPAP, and TPC-1 thyroid tumor cell lines display different profile in both basal and TNF-α-induced CXCL8 secretion 94
Temporal relationship between the appearance of thyroid autoantibodies and development of destructive thyroiditis in patients undergoing treatment with two different type-1 interferons for HCV-related chronic hepatitis: a prospective study. 93
Metformin reverts the secretion of CXCL8 induced by TNF-α in primary cultures of human thyroid cells: An additional indirect anti-tumor effect of the drug 93
Per-polyfluoroalkyl substances (PFAS) as thyroid disruptors: is there evidence for multi-transgenerational effects? 92
Increase of interferon-gamma inducible alpha chemokine CXCL10 but not beta chemokine CCL2 serum levels in chronic autoimmune thyroiditis. 92
Iodized salt improves the effectiveness of L-thyroxine therapy after surgery for nontoxic goitre: a prospective and randomized study. 91
Increased serum CXCL10 in Graves' disease or autoimmune thyroiditis is not associated with hyper- or hypothyroidism per se, but is specifically sustained by the autoimmune, inflammatory process. 91
CXCR3-mediated opposite effects of CXCL10 and CXCL4 on TH1 or TH2 cytokine production. 91
Repeated laser thermal ablation of a large functioning thyroid nodule restores euthyroidism and ameliorates constrictive symptoms. 91
Graves'-like orbitopathy in a patient with chronic autoimmune pancreatitis. 91
Cardiovascular abnormalities in Klinefelter Syndrome 91
Interferon-gamma-inducible alpha-chemokine CXCL10 involvement in Graves' ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists. 90
Leptin as a marker of multiple sclerosis activity in patients treated with interferon-beta. 90
Totale 11.653
Categoria #
all - tutte 106.925
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.925


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022741 0 0 0 0 24 27 15 57 50 7 140 421
2022/20232.750 288 148 68 238 260 266 0 152 1.208 16 74 32
2023/20241.034 145 178 37 74 86 224 26 58 4 29 58 115
2024/20253.143 51 234 52 143 87 196 139 236 788 143 270 804
2025/20268.476 491 529 1.118 986 919 370 1.619 412 683 604 384 361
2026/20273.134 447 551 779 1.339 18 0 0 0 0 0 0 0
Totale 23.373